Hybio Pharmaceutical Co.,Ltd. Fundamental Rankings
This page is comprehensive fundamental data for Hybio Pharmaceutical Co.,Ltd.. Fundamentals are ordered by how Hybio Pharmaceutical Co.,Ltd. ranks compared to other companies (ordered high to low). All money values are in CNY. All data is powered by Quandl.
Cite in Wikipedia:
| Indicator | Value | n/price | Rank | Date | Historic |
|---|---|---|---|---|---|
| Goodwill | 923,781,187 | 0.05712 | 83 | 2015-06-30 | historic |
| Cash from issuing bonds | 198,600,000 | 0.01228 | 93 | 2015-06-30 | historic |
| Diluted eps | 0 | 0.0 | 183 | 2015-06-30 | historic |
| Other current liabilities | 1,927,124 | 1.2E-4 | 326 | 2015-06-30 | historic |
| Long term accounts payable | 3,500,000 | 2.2E-4 | 333 | 2015-06-30 | historic |
| Interest receivable | 273,448 | 2.0E-5 | 399 | 2015-06-30 | historic |
| Net cashflow from financing activities | 374,947,959 | 0.02319 | 429 | 2015-06-30 | historic |
| Purchases of fixed assets and others | 194,911,386 | 0.01205 | 451 | 2015-06-30 | historic |
| Interests payable | 4,319,444 | 2.7E-4 | 493 | 2015-06-30 | historic |
| Intangible assets | 295,901,685 | 0.0183 | 577 | 2015-06-30 | historic |
| Cash paid for other financing activities | 506,085 | 3.0E-5 | 688 | 2015-06-30 | historic |
| Non-operating loss | 913,404 | 6.0E-5 | 726 | 2015-06-30 | historic |
| Long term equity investment | 18,340,800 | 0.00113 | 731 | 2015-06-30 | historic |
| Financial expenses | 13,570,211 | 8.4E-4 | 740 | 2015-06-30 | historic |
| Cash inflows from financing activities | 656,699,992 | 0.04061 | 773 | 2015-06-30 | historic |
| Total non-current assets | 2,325,785,250 | 0.14382 | 791 | 2015-06-30 | historic |
| Disposal of fixed assets and others | 10,000 | 0.0 | 791 | 2015-06-30 | historic |
| Refunds of taxes | 83,542 | 1.0E-5 | 796 | 2015-06-30 | historic |
| Net income | 89,683,801 | 0.00555 | 798 | 2015-06-30 | historic |
| Total comprehensive income | 89,541,058 | 0.00554 | 799 | 2015-06-30 | historic |
| Operating profit | 90,878,305 | 0.00562 | 801 | 2015-06-30 | historic |
| Total profit | 98,500,372 | 0.00609 | 840 | 2015-06-30 | historic |
| Fixed assets | 739,213,674 | 0.04571 | 859 | 2015-06-30 | historic |
| Capital reserve | 995,955,335 | 0.06159 | 862 | 2015-06-30 | historic |
| Cash paid for dividends, profits or interests | 57,145,948 | 0.00353 | 873 | 2015-06-30 | historic |
| Notes receivable | 10,896,785 | 6.7E-4 | 885 | 2015-06-30 | historic |
| Other payables | 57,838,393 | 0.00358 | 901 | 2015-06-30 | historic |
| Deferred tax assets | 16,658,894 | 0.00103 | 924 | 2015-06-30 | historic |
| Selling expenses | 34,575,966 | 0.00214 | 950 | 2015-06-30 | historic |
| Payroll payable | 12,821,114 | 7.9E-4 | 1019 | 2015-06-30 | historic |
| Prepayment | 34,232,337 | 0.00212 | 1058 | 2015-06-30 | historic |
| Cash paid for taxes | 46,374,535 | 0.00287 | 1116 | 2015-06-30 | historic |
| Net change in cash | -470,985,500 | -0.02912 | 1155 | 2015-06-30 | historic |
| Total liabilities | 640,734,853 | 0.03962 | 1170 | 2015-06-30 | historic |
| Other receivables | 10,432,815 | 6.5E-4 | 1171 | 2015-06-30 | historic |
| Total liabilities and equity | 3,050,621,448 | 0.18864 | 1177 | 2015-06-30 | historic |
| Net cash flows from investing activities | -865,775,989 | -0.05354 | 1191 | 2015-06-30 | historic |
| Inventories | 110,583,929 | 0.00684 | 1193 | 2015-06-30 | historic |
| Net cash and cash equivalents ending balance | 229,070,519 | 0.01416 | 1198 | 2015-06-30 | historic |
| Revenue | 265,417,873 | 0.01641 | 1295 | 2015-06-30 | historic |
| Cash inflows from operating activities | 248,479,433 | 0.01537 | 1299 | 2015-06-30 | historic |
| Total cost of goods sold | 175,049,568 | 0.01082 | 1300 | 2015-06-30 | historic |
| Cash outflows from operating activities | 228,586,109 | 0.01414 | 1315 | 2015-06-30 | historic |
| Accounts payable | 16,539,706 | 0.00102 | 1319 | 2015-06-30 | historic |